Aging cell

Biological Aging Patterns in People with Extra or Missing Sex Chromosomes

Updated

Abstract

Essence

Extra X chromosome dosage in 47,XXY was associated with slower DNA methylation aging on some epigenetic clocks, but not all of them.

Evidence

This whole-blood DNA methylation analysis compared people with 46,XX, 46,XY, 47,XXY, and 47,XYY karyotypes and found lower GrimAge and slower DunedinPACE in 47,XXY versus 46,XY, while the Skin & Blood clock showed higher in 47,XXY and 47,XYY.

Caveat

The result is limited by discordant clock readouts and the need for larger, age-spanning studies with direct phenotyping to clarify what these methylation measures mean biologically.

Simplified

Key numbers

< 0.001
Lower GrimAge in 47,XXY
Comparison of GrimAge between 47,XXY males and 46,XY males.
< 0.001
Lower in 47,XXY
estimates for 47,XXY males vs. 46,XX females.
< 0.01
Higher in 47,XYY
Skin & Blood clock results for 47,XYY males compared to 46,XY males.

Key figures

FIGURE 1
estimates versus chronological age across six DNA methylation clocks in groups
Frames how different DNA methylation clocks relate epigenetic age to chronological age across sex chromosome variations
ACEL-24-e70243-g002
  • Panel A
    epigenetic age plotted against chronological age for groups XX, XX SRY+, XXY, XY, XY , and XYY with lines
  • Panel B
    epigenetic age versus chronological age with linear regression lines for all six groups
  • Panel C
    Skin & Blood clock epigenetic age versus chronological age with linear regression lines for all groups
  • Panel D
    epigenetic age versus chronological age with linear regression lines for all groups
  • Panel E
    epigenetic age versus chronological age with linear regression lines for all groups
  • Panel F
    epigenetic age versus chronological age with linear regression lines for all groups
FIGURE 2
estimates across six DNA methylation clocks in different sex chromosome groups
Highlights distinct epigenetic aging patterns across sex chromosome aneuploidies, with GrimAge showing lower acceleration in XXY males.
ACEL-24-e70243-g004
  • Panel A
    values for XX females, XX SRY+ phenotypic males, XXY males, XY males, XY phenotypic females, and XYY males; XX and XY groups show higher mean values than XXY and XX SRY+ groups with significant differences indicated.
  • Panel B
    values for the same groups; values appear near zero with no significant differences indicated.
  • Panel C
    age acceleration values showing higher means in XY CAIS phenotypic females and XYY males compared to XXY males, with significant differences between these groups.
  • Panel D
    age acceleration values across groups showing mostly near-zero means without significant differences.
  • Panel E
    age acceleration values with XX and XY groups showing higher means than XXY and XX SRY+ groups, with significant differences indicated.
  • Panel F
    age acceleration values showing a significant difference between XY CAIS phenotypic females (lower mean) and XY males (higher mean).
FIGURE 3
DNA methylation surrogates of GrimAge components across sex chromosome groups
Highlights distinct GrimAge component patterns with higher leptin and cystatin C surrogates in XX females versus males
ACEL-24-e70243-g001
  • Panel A
    Age-adjusted leptin surrogate levels for XX females, XX SRY+ phenotypic males, XXY males, XY males, XY phenotypic females, and XYY males; XX females show visibly higher mean values than most groups
  • Panel B
    Age-adjusted DNAm adrenomedullin surrogate levels across groups; XX females appear to have higher mean values than XY CAIS phenotypic females and XYY males
  • Panel C
    Age-adjusted DNAm tissue inhibitor of metalloproteinase 1 surrogate levels across groups; XX females and XY CAIS phenotypic females show higher means than XXY males
  • Panel D
    Age-adjusted DNAm growth differentiation factor 15 surrogate levels across groups; XX SRY+ phenotypic males and XY males show higher means than XX females and XY CAIS phenotypic females
  • Panel E
    Age-adjusted DNAm cystatin C surrogate levels across groups; XX females show higher mean values than XXY males and XY males
  • Panel F
    Age-adjusted DNAm smoking pack-years surrogate levels across groups; XY CAIS phenotypic females show higher mean values than XX SRY+ phenotypic males
  • Panel G
    Age-adjusted DNAm plasminogen activator inhibitor 1 surrogate levels across groups; XX females show higher mean values than XXY males and XY CAIS phenotypic females
  • Panel H
    Age-adjusted DNAm beta-2 microglobulin surrogate levels across groups; XX females show higher mean values than XXY males, XY males, and XY CAIS phenotypic females
FIGURE 4
estimates in groups with different sex chromosome compositions and phenotypes
Highlights slower epigenetic aging pace in XXY males compared to XY males and XX females
ACEL-24-e70243-g005
  • Panel single
    Bar plots show mean DunedinPACE values with standard error for XX females, XX SRY+ phenotypic males, XXY males, XY males, XY phenotypic females, and XYY males; pink bars represent phenotypic females and light blue bars represent phenotypic males
  • Panel single
    XXY males have visibly lower DunedinPACE estimates compared to XY males and XX females
  • Panel single
    Significance brackets indicate statistically lower DunedinPACE in XXY males versus XX females (**), XXY males versus XY males (), and XX SRY+ phenotypic males versus XX females (*)
FIGURE 5
Estimated abundance of exhausted and across sex chromosome groups
Highlights contrasting CD8T cell abundance patterns between phenotypic females and males across sex chromosome variations.
ACEL-24-e70243-g006
  • Panel A
    Estimated abundance of in groups XX, XX SRY+ phenotypic males, XXY males, XY males, XY phenotypic females, and XYY males; XX females show visibly higher abundance compared to XX SRY+ and XY males.
  • Panel B
    Estimated abundance of naïve CD8T cells in the same groups; XX SRY+ phenotypic males appear to have lower abundance compared to XX females and XY males.
1 / 5

Full Text

What this is

  • This research investigates how sex chromosome aneuploidies influence epigenetic aging through DNA methylation clocks.
  • It compares epigenetic age and in individuals with different karyotypes: 46,XX, 46,XY, 47,XXY, and 47,XYY.
  • Findings indicate that 47,XXY individuals exhibit slower biological aging compared to 46,XY males, while 47,XYY shows differing patterns.

Essence

  • Individuals with the 47,XXY karyotype show lower epigenetic and slower aging compared to 46,XY males. In contrast, the 47,XYY group exhibits distinct aging characteristics, suggesting that sex chromosome dosage affects biological aging.

Key takeaways

  • 47,XXY males exhibit lower GrimAge and DunedinPACE values compared to 46,XY males, indicating slower biological aging. This suggests that the additional X chromosome may mitigate certain aging processes.
  • The Skin & Blood clock indicates higher in both 47,XXY and 47,XYY compared to 46,XY, revealing discrepancies in aging assessments across different epigenetic clocks.
  • Epigenome-wide association studies reveal that 47,XXY is associated with immune-related methylation changes, while 47,XYY shows distinct enrichments in renal and metabolic pathways, highlighting the biological diversity among these aneuploidies.

Caveats

  • The study's cross-sectional design limits the ability to assess how epigenetic aging patterns may change over time. Longitudinal studies are necessary to confirm these findings.
  • Sample size was relatively small, which may restrict the statistical power and generalizability of the results. Larger cohorts are needed for more robust conclusions.
  • Potential ascertainment bias exists, as the 47,XXY group comprises clinically diagnosed individuals, which may not represent the broader population of individuals with this karyotype.

Definitions

  • epigenetic clock: A biomarker that uses DNA methylation patterns to estimate biological age and aging processes.
  • age acceleration: The difference between an individual's epigenetic age and their chronological age, indicating the rate of biological aging.

Simplified

Funding

Competing interests

1 of 8
authors report competing interests
7 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free